Abstract
Background: Neurological disorders in kidney transplant patients may be related to several factors, including high toxicity to the use of immunosuppressive drugs.
Objective: To find out whether there was association between neurological complications and immunosuppression in a sample of patients who received renal transplantation.
Methods: Cross-sectional study in which 121 renal transplant patients participated, of which 22 (18%) had neurological disorders, χ2 was used to analyze the relation between neurological disorders and comorbidity such as diabetes mellitus and hypertension and time of immunosuppressant use. A significance level of p <0.05 was accepted for all determinations
Results: Of the subjects studied, 13 were male (59%) and nine female (41%). The mean age of the patients included in the study was 33 ± 12 years. 59% of neurological disorders occurred between six months and five years after patients had received the transplant. Neurological alterations found were: tremor (7.4%), dizziness (4.1%), peripheral neuropathy (3.3%), headache (2.4%), and decreased strength (0.8%).
Conclusion: No statistically significant association was found between neurological disorders and immunosuppressant use, or between them and the duration of immunosuppression.
References
Patchell RA. Neurological complications of organ transplantation. Ann Neurol. 1994;36(5):688-703. doi: 10.1002/ana.410360503
Martínez AJ. The neuropathology of organ transplantation: comparison and contrast in 500 patients. Pathol Res Pract. 1998;194(7):473-86.
Jindal RM, Ryan JJ, Sajjad I, Murthy MH, Baines LS. Kidney transplantation and gender disparity. Am J Nephrol. 2005;25(5):474-483. doi: 10.1159/000087920
Jost L, Nogues M, Dávalos M, Turín M, Manes F, Leiguarda R. Complicaciones neurológicas del trasplante renal. Medicina (B Aires) 2000;60:161-164.
Secretaría de Salud. Guía de práctica clínica. Terapia inmunosupresora en el trasplante renal, México: Secretaría de Salud; 2008. Disponible en: http://cvsp.cucs.udg.mx/guias/TODAS/IMSS_112_08_TERAPIA_INMUNOSUPRESORA_TRASPLANTE_RENAL/IMSS_112_08_EyR.pdf
Gatault P, Bertrand D, Büchler M, Colosio C, Hurault de Ligny B, Weestel PF, et al. Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation. Transpl Int. 2016;29(1):41-50. doi: 10.1111/tri.12656
Fernández-Ramos JA, López-Lasoa E, Ordónez-Díaz MD, Camino-Leóna R, Ibarra-de la Rosa I, Frías-Pérez MA, et al. Complicaciones neurológicas en trasplantados de órgano sólido. An Pediatr (Barc). 2013;78(3):149-156. doi:10.1016/j.anpedi.2012.08.001
Soria V. Trastornos neuropsiquiátricos asociados al uso de ciclosporina en pacientes trasplantados. Psiq Biol. 2002;9(4):158-163.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2016 Revista Alergia México